COVID-19 Vaccination

Effective April 7, 2021:
If you are 18 or older, you are eligible to receive your vaccine.
(Includes first responders in Phase 1a)

North East Mobile Health Services is now offering public COVID-19 vaccination clinic sites in Portland, Windham, Jackman and Lincolnville. Please “Click to Register” below using our online form. We will schedule more clinics as vaccine becomes available. Please follow our Facebook page for more updates.

All COVID-19 Vaccines are free of charge and have NO out-of-pocket expense to ANY individual.

We do ask for health insurance information because we are allowed to charge a small administration fee that has NO copay or deductible responsibilities to the insured. The government covers all administration fees for any individual without health insurance.

Some of our vaccine clinics operates multiple “lanes” in order to make the vaccination process as fast and convenient as possible. If your desired appointment time, please check other lanes.

Upcoming Clinics

Lincolnville, Maine

Date: Saturday, April 10, 2021
Time: 10:00 a.m. – 12:30 p.m.

Vaccine: Janssen (Johnson & Johnson)

Location:
Lincolnville Community Building
18 Searsmont Rd., Lincolnville

Sorry, this clinic is FULL.

Please check back often for updates.

Portland, Maine

Date: Monday, April 12, 2021
Time: 10:00 a.m. – 3:00 p.m.

Vaccine: Janssen (Johnson & Johnson)

Location:
Italian Heritage Center
40 Westland Ave., Portland

Sorry, this clinic is FULL.

Please check back often for updates.

Windham, Maine

Date: Tuesday, April 13, 2021
Time: 10:00 a.m. – 3:00 p.m.

Vaccine: Janssen (Johnson & Johnson)

Location:
Windham Veterans Center
35 Veterans Memorial Dr., Windham

Sorry, this clinic is FULL.

Please check back often for updates.

Jackman, Maine

Date: Friday, April 2, 2021
Time: 3:00 p.m. – 5:00 p.m.

Vaccine: Moderna

Location:
Forest Hills High School
606 Main St., Jackman

Lane 1 – Click here to register

Jackman, Maine

Date: Friday, April 2, 2021
Time: 6:00 p.m. – 8:30 p.m.

Vaccine: Janssen (Johnson & Johnson)

Location:
Forest Hills High School
606 Main St., Jackman

Lane 1 – Click here to register

Bingham, Maine

Date: Saturday, March 6, 2021
Time: 10:00 a.m. – 2:00 p.m.

Vaccine: Janssen (Johnson & Johnson)

Location:
Former Quimby Elementary School
263 Main St., Bingham

SORRY, THIS CLINIC IS FULL.

Please check back often for updates.

We're working hard to vaccinate our community!

Bingham

0
Doses Administered

Jackman

0
Doses Administered

Lincolnville

0
Doses Administered

Please follow our Facebook page for more updates.

We will be administering two different types of vaccines, depending on availability. For more information about the specific vaccine you received, click the button below:

FACT SHEET FOR RECIPIENTS AND CAREGIVERS 

EMERGENCY USE AUTHORIZATION (EUA) OF THE JANSSEN COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019  (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER 

You are being offered the Janssen COVID-19 Vaccine to prevent Coronavirus Disease 2019  (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to help you  understand the risks and benefits of receiving the Janssen COVID-19 Vaccine, which you may  receive because there is currently a pandemic of COVID-19. 

The Janssen COVID-19 Vaccine may prevent you from getting COVID-19. There is no U.S. Food  and Drug Administration (FDA) approved vaccine to prevent COVID-19. 

Read this Fact Sheet for information about the Janssen COVID-19 Vaccine. Talk to the vaccination  provider if you have questions. It is your choice to receive the Janssen COVID-19 Vaccine

The Janssen COVID-19 Vaccine is administered as a single dose, into the muscle. The Janssen COVID-19 Vaccine may not protect everyone. 

This Fact Sheet may have been updated. For the most recent Fact Sheet, please visit www.janssencovid19vaccine.com.

COVID-19 is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Common symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.

The Janssen COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19.

The FDA has authorized the emergency use of the Janssen COVID-19 Vaccine to prevent COVID-19 in individuals 18 years of age and older under an Emergency Use Authorization (EUA).

For more information on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet.

Tell the vaccination provider about all of your medical conditions, including if you:

  • have any allergies
  • have a fever
  • have a bleeding disorder or are on a blood thinner
  • are immunocompromised or are on a medicine that affects your immune system
  • are pregnant or plan to become pregnant
  • are breastfeeding
  • have received another COVID-19 vaccine

FDA has authorized the emergency use of the Janssen COVID-19 Vaccine in individuals 18 years of age and older.

You should not get the Janssen COVID-19 Vaccine if you:

  • had a severe allergic reaction to any ingredient of this vaccine.

The Janssen COVID-19 Vaccine includes the following ingredients: recombinant, replication-incompetent adenovirus type 26 expressing the SARS-CoV-2 spike protein, citric acid monohydrate, trisodium citrate dihydrate, ethanol, 2-hydroxypropyl-β-cyclodextrin (HBCD), polysorbate-80, sodium chloride.

The Janssen COVID-19 Vaccine will be given to you as an injection into the muscle.

The Janssen COVID-19 Vaccine vaccination schedule is a single dose.

The Janssen COVID-19 Vaccine is an unapproved vaccine. In an ongoing clinical trial, 21,895 individuals 18 years of age and older have received the Janssen COVID-19 Vaccine.

In an ongoing clinical trial, the Janssen COVID-19 Vaccine has been shown to prevent COVID-19 following a single dose. The duration of protection against COVID-19 is currently unknown.

Side effects that have been reported with the Janssen COVID-19 Vaccine include:

  • Injection site reactions: pain, redness of the skin and swelling.
  • General side effects: headache, feeling very tired, muscle aches, nausea, and fever.


There is a remote chance that the Janssen COVID-19 Vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Janssen COVID-19 Vaccine. For this reason, your vaccination provider may ask you to stay at the place where you received your vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include:

  • Difficulty breathing,
  • Swelling of your face and throat
  • A fast heartbeat
  • A bad rash all over your body
  • Dizziness and weakness.


These may not be all the possible side effects of the Janssen COVID-19 Vaccine. Serious and unexpected effects may occur. The Janssen COVID-19 Vaccine is still being studied in clinical trials.

If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. 

Call the vaccination provider or your healthcare provider if you have any side effects that bother  you or do not go away. 

Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS).  The VAERS toll-free number is 1-800-822-7967 or report online to  https://vaers.hhs.gov/reportevent.html. Please include “Janssen COVID-19 Vaccine EUA” in the first line of box #18 of the report form. 

In addition, you can report side effects to Janssen Biotech, Inc. at the contact information provided  below.

E-mail 

Fax number 

Telephone numbers

JNJvaccineAE@its.jnj.com 

215-293-9955 

US Toll Free:
1-800-565-4008

US Toll:
(908) 455-9922

You may also be given an option to enroll in v-safe. V-safe is a new voluntary smartphone-based  tool that uses text messaging and web surveys to check in with people who have been vaccinated  to identify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC  monitor the safety of COVID-19 vaccines. V-safe also provides live telephone follow-up by CDC  if participants report a significant health impact following COVID-19 vaccination. For more  information on how to sign up, visit: www.cdc.gov/vsafe.

It is your choice to receive or not receive the Janssen COVID-19 Vaccine. Should you decide not to receive it, it will not change your standard medical care.

Currently, there is no FDA approved alternative vaccine available for prevention of COVID-19. Other vaccines to prevent COVID-19 may be available under Emergency Use Authorization.

There is no information on the use of the Janssen COVID-19 Vaccine with other vaccines.

If you are pregnant or breastfeeding, discuss your options with your healthcare provider.

No. The Janssen COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.

When you receive the Janssen COVID-19 Vaccine, you will get a vaccination card to document the name of the vaccine and date of when you received the vaccine.

If you have questions or to access the most recent Janssen COVID-19 Vaccine Fact Sheets, visit the website or call the telephone numbers provided below.

Fact Sheets Website Telephone numbers
www.janssencovid19vaccine.com US Toll Free:
1-800-565-4008

US Toll:
(908) 455-9922

 


Contact your local or state public health department.

The vaccination provider may include your vaccination information in your state/local jurisdiction’s Immunization Information System (IIS) or other designated system. For more information about IISs visit: https://www.cdc.gov/vaccines/programs/iis/about.html.

The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses for certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp or call 1-855-266-2427.

The United States FDA has made the Janssen COVID-19 Vaccine available under an emergency access mechanism called an EUA. The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic.

The Janssen COVID-19 Vaccine has not undergone the same type of review as an FDA-approved or cleared product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, and available alternatives. In addition, the FDA decision is based on the totality of scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used during the COVID-19 pandemic.

The EUA for the Janssen COVID-19 Vaccine is in effect for the duration of the COVID-19 declaration justifying emergency use of these products, unless terminated or revoked (after which the products may no longer be used).

© 2021 Janssen Pharmaceutical Companies 

Revised: Feb/27/2021

FACT SHEET FOR RECIPIENTS AND CAREGIVERS 

EMERGENCY USE AUTHORIZATION (EUA) OF THE MODERNA COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019  (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER 

You are being offered the Moderna COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to help you understand the risks and benefits of the Moderna COVID-19 Vaccine, which you may receive because there is currently a pandemic of COVID-19.

The Moderna COVID-19 Vaccine is a vaccine and may prevent you from getting COVID-19. There is no U.S. Food and Drug Administration (FDA) approved vaccine to prevent COVID-19.

Read this Fact Sheet for information about the Moderna COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Moderna COVID-19 Vaccine.

The Moderna COVID-19 Vaccine is administered as a 2-dose series, 1 month apart, into the muscle.

The Moderna COVID-19 Vaccine may not protect everyone.

This Fact Sheet may have been updated. For the most recent Fact Sheet, please visit www.modernatx.com/covid19vaccine-eua.

COVID-19 is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Common symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.

The Moderna COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19.

The FDA has authorized the emergency use of the Moderna COVID-19 Vaccine to prevent COVID-19 in individuals 18 years of age and older under an Emergency Use Authorization (EUA).

For more information on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet.

Tell the vaccination provider about all of your medical conditions, including if you:

  • have any allergies
  • have a fever
  • have a bleeding disorder or are on a blood thinner
  • are immunocompromised or are on a medicine that affects your immune system
  • are pregnant or plan to become pregnant
  • are breastfeeding
  • have received another COVID-19 vaccine

FDA has authorized the emergency use of the Moderna COVID-19 Vaccine in individuals 18 years of age and older.

You should not get the Moderna COVID-19 Vaccine if you:

  • had a severe allergic reaction after a previous dose of this vaccine
  • had a severe allergic reaction to any ingredient of this vaccine.

The Moderna COVID-19 Vaccine contains the following ingredients: messenger ribonucleic acid (mRNA), lipids (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG], cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC]), tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate, and sucrose.

The Moderna COVID-19 Vaccine will be given to you as an injection into the muscle.

The Moderna COVID-19 Vaccine vaccination series is 2 doses given 1 month apart.

If you receive one dose of the Moderna COVID-19 Vaccine, you should receive a second dose of
the same vaccine 1 month later to complete the vaccination series.

The Moderna COVID-19 Vaccine is an unapproved vaccine. In clinical trials, approximately 15,400 individuals 18 years of age and older have received at least 1 dose of the Moderna COVID-19 Vaccine.

In an ongoing clinical trial, the Moderna COVID-19 Vaccine has been shown to prevent COVID-19 following 2 doses given 1 month apart. The duration of protection against COVID-19 is currently unknown.

Side effects that have been reported with the Moderna COVID-19 Vaccine include:

  • Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm of the injection, swelling (hardness), and redness.
  • General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, and fever.


There is a remote chance that the Moderna COVID-19 Vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Janssen COVID-19 Vaccine. For this reason, your vaccination provider may ask you to stay at the place where you received your vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include:

  • Difficulty breathing,
  • Swelling of your face and throat
  • A fast heartbeat
  • A bad rash all over your body
  • Dizziness and weakness.


These may not be all the possible side effects of the Moderna COVID-19 Vaccine. Serious and unexpected effects may occur. The Moderna COVID-19 Vaccine is still being studied in clinical trials.

If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. 

Call the vaccination provider or your healthcare provider if you have any side effects that bother  you or do not go away. 

Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS).  The VAERS toll-free number is 1-800-822-7967 or report online to  https://vaers.hhs.gov/reportevent.html. Please include “Moderna COVID-19 Vaccine EUA” in the first line of box #18 of the report form. 

In addition, you can report side effects to ModernaTX, Inc. at 1-866-MODERNA (1-866-663-3762).

You may also be given an option to enroll in v-safe. V-safe is a new voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated
to identify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC monitor the safety of COVID-19 vaccines. V-safe also provides second-dose reminders if needed and live telephone follow-up by CDC if participants report a significant health impact following COVID-19 vaccination. For more information on how to sign up, visit:
www.cdc.gov/vsafe.

It is your choice to receive or not receive the Moderna COVID-19 Vaccine. Should you decide not to receive it, it will not change your standard medical care.

Currently, there is no FDA approved alternative vaccine available for prevention of COVID-19. Other vaccines to prevent COVID-19 may be available under Emergency Use Authorization.

There is no information on the use of the Moderna COVID-19 Vaccine with other vaccines.

If you are pregnant or breastfeeding, discuss your options with your healthcare provider.

No. The Moderna COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.

When you receive your first dose, you will get a vaccination card to show you when to return for your second dose of the Moderna COVID-19 Vaccine. Remember to bring your card when you return.

If you have questions or to access the most recent Moderna COVID-19 Vaccine Fact Sheets, visit the website or call the telephone numbers provided below.

Fact Sheets Website Telephone numbers
https://www.modernatx.com/covid19vaccine-eua

1-866-MODERNA
(1-866-663-3762)

  • Ask the vaccination provider. 
  • Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html
  • Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal regulatory-and-policy-framework/emergency-use-authorization.
  • Contact your local or state public health department.

The vaccination provider may include your vaccination information in your state/local jurisdiction’s Immunization Information System (IIS) or other designated system. This will ensure that you receive the same vaccine when you return for the second dose. For more information about IISs visit: https://www.cdc.gov/vaccines/programs/iis/about.html.

The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses for certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp or call 1-855-266-2427.

The United States FDA has made the Moderna COVID-19 Vaccine available under an emergency access mechanism called an EUA. The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic.

The Moderna COVID-19 Vaccine has not undergone the same type of review as an FDA approved or cleared product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, and available alternatives. In addition, the FDA decision is based on the totality of the scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used during the COVID-19 pandemic.

The EUA for the Moderna COVID-19 Vaccine is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of these products, unless terminated or revoked (after which the products may no longer be used).

©2020 ModernaTX, Inc. All rights reserved.

Revised: 12/2020